Prosecution Insights
Last updated: October 02, 2026

Examiner: ARON, KIMBERLY A

Tech Center 1600 • Art Units: 1633 1647 1653 1655

This examiner grants 54% of resolved cases

Analysis

Kimberly A. Aron serves in Tech Center 1600 and Art Unit 1633. She has 435 resolved cases with an allowance rate of 54.7 percent. This 54.7 percent rate indicates the frequency of granted patents among the 435 resolved cases. Practitioners can use these figures to evaluate the prosecution environment and the likelihood of success in this technology area.

The interview lift is 34.9 percent, which is a statistic that shows the change in allowance probability following an interview. This 34.9 percent lift is a notable metric for developing a strategy. The median days to allowance is 1281, providing a benchmark for the time required to reach a grant. This 1281-day median is a key data point for managing expectations. These figures from Tech Center 1600 and Art Unit 1633 serve as the basis for understanding the examiner's historical performance and the duration of the prosecution cycle.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

54.5%
Allow Rate
-5.5% vs TC avg
457
Total Applications
+35.2%
Interview Lift
1282
Avg Prosecution Days
Based on 437 resolved cases, 2023–2026

Rejection Statute Breakdown

4.2%
§101 Eligibility
12.1%
§102 Novelty
40.5%
§103 Obviousness
26.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17618774 RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS Final Rejection University of Washington
18069650 METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS Final Rejection University of Cincinnati
18507432 NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES Non-Final OA The Brigham and Women's Hospital, Inc.
18519972 METHODS AND COMPOSITIONS FOR TREATING METASTATIC BREAST CANCER AND OTHER CANCERS IN THE BRAIN Non-Final OA The Trustees of the University of Pennsylvania
18135836 Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule Final Rejection Wayne State University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month